Veracyte, Inc. Selling, General, and Administrative Expenses (SG&A) for the Trailing 12 Months (TTM) ending March 31, 2025: USD 217.18 M

Veracyte, Inc. Selling, General, and Administrative Expenses (SG&A) is USD 217.18 M for the Trailing 12 Months (TTM) ending March 31, 2025, a 16.35% change year over year. Selling, general, and administrative (SG&A) expenses are the expenses related to the sales and marketing efforts, as well as general and administrative functions of a company.
  • Veracyte, Inc. Selling, General, and Administrative Expenses (SG&A) for the Trailing 12 Months (TTM) ending March 31, 2024 was USD 186.67 M, a 5.19% change year over year.
  • Veracyte, Inc. Selling, General, and Administrative Expenses (SG&A) for the Trailing 12 Months (TTM) ending March 31, 2023 was USD 177.47 M, a 6.03% change year over year.
  • Veracyte, Inc. Selling, General, and Administrative Expenses (SG&A) for the Trailing 12 Months (TTM) ending March 31, 2022 was USD 167.38 M, a 30.78% change year over year.
  • Veracyte, Inc. Selling, General, and Administrative Expenses (SG&A) for the Trailing 12 Months (TTM) ending March 31, 2021 was USD 127.99 M, a 45.96% change year over year.
Key Data
Date Selling, General, and Administrative Expenses (SG&A) Research and Development (R&D) Expenses Revenue Revenue